During the past decade, Arizona Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arizona Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Arizona Oncology" are "Carcinoma, Renal Cell" (1 trials), "Fallopian Tube Cancer" (1 trials), "Hepatic Veno-Occlusive Disease" (1 trials), "High Grade Cervical Intraepithelial Neoplasia" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Arizona Oncology" in a lesser frequency.

Most popular intervention types in "Arizona Oncology" are "Drug" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Defibrotide" (1 trials), "DySIS" (1 trials), "Sorafenib" (1 trials), "biologic sample preservation procedure" (1 trials) and "cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arizona Oncology" are 2 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Arizona Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Arizona Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Arizona Oncology, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".